We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A group of physicians and advocacy groups is taking on pharmaceutical promotions, calling in a journal article for an overhaul of the way healthcare professionals are educated on how to handle them.
It is becoming increasingly important for pharmaceutical companies to address the issue of fair market value in their dealings with key opinion leaders (KOLs), according to experts on the issue.
Merck announced a national print, television and online advertising campaign to promote and educate consumers about its cervical cancer vaccine Gardasil.
Boston Scientific, a worldwide developer, manufacturer and marketer of medical devices, announced last week that Steven Zelenkofske has been appointed as the patient safety officer and vice president of clinical sciences for the company's Cardiac Rhythm Management (CRM) Group.
Eli Lilly, Pfizer and Bristol-Myers Squibb (BMS) have joined AstraZeneca as targets of subpoenas from the California Office of the Attorney General (AG) over marketing practices for top-selling antipsychotic drugs.
The Department of Justice (DOJ) has entered into another multimillion-dollar, off-label promotion settlement, which sources say reflects an enforcement priority for the federal government.
Qiagen inappropriately marketed several of its products as analyte-specific reagents (ASRs) and must apply for new FDA approvals, the agency said in a recent warning letter.
The growing use of internet advertising benefits smaller pharmaceutical companies that lack the resources to compete using more traditional methods to market their products, industry observers say.
The Association of the British Pharmaceutical Industry (ABPI) has suspended Merck Sharp & Dohme (MSD) for at least three months for violations of the industry group's code of ethics.